1.3.8.8: long-chain acyl-CoA dehydrogenase
This is an abbreviated version!
For detailed information about long-chain acyl-CoA dehydrogenase, go to the full flat file.
Word Map on EC 1.3.8.8
-
1.3.8.8
-
medium-chain
-
beta-oxidation
-
carnitine
-
acylcarnitine
-
cardiomyopathy
-
cardiac
-
peroxisome
-
triglyceride
-
rhabdomyolysis
-
hypoglycemia
-
acadvl
-
palmitoyltransferase
-
proliferator-activated
-
inborn
-
trifunctional
-
nbs
-
3-hydroxyacyl-coa
-
acidurias
-
myopathic
-
hypoketotic
-
glutaric
-
myoglobinuria
-
dehydrogenase-deficient
-
isovaleryl-coa
-
bezafibrate
-
lchad
-
faods
-
medicine
-
mcadd
- 1.3.8.8
-
medium-chain
-
beta-oxidation
- carnitine
- acylcarnitine
- cardiomyopathy
- cardiac
- peroxisome
- triglyceride
- rhabdomyolysis
- hypoglycemia
- acadvl
- palmitoyltransferase
-
proliferator-activated
-
inborn
-
trifunctional
- nbs
- 3-hydroxyacyl-coa
- acidurias
-
myopathic
-
hypoketotic
-
glutaric
- myoglobinuria
-
dehydrogenase-deficient
- isovaleryl-coa
- bezafibrate
- lchad
-
faods
- medicine
-
mcadd
Reaction
Synonyms
ACAD 9, AcdB, acyl-CoA dehydrogenase 9, BACH, CTE-II, EC 1.3.99.13, EC 1.3.99.3, LCAD, long chain acyl coenzyme A dehydrogenase, long chain acyl-CoA dehydrogenase, long-chain acyl-CoA dehydrogenase, long-chain acyl-CoA hydrolase, long-chain acyl-coenzyme A dehydrogenase, MCAD, medium long-chain acyl-CoA dehydrogenase, More, MTE-II, palmitoyl-CoA dehydrogenase, palmitoyl-coenzyme A dehydrogenase, PtmO4, type-II acyl-CoA thioesterase, very long chain acyl-CoA dehydrogenase, very long-chain acyl-CoA dehydrogenase, very-long-chain acyl-CoA dehydrogenase, very-long-chain acyl-coenzyme A dehydrogenase, VLCAD, VLMCAD
ECTree
Advanced search results
Activating Compound
Activating Compound on EC 1.3.8.8 - long-chain acyl-CoA dehydrogenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Clofibrate
-
activation, treated animals receiving 0.5% w/w neutralized acid for 2 weeks
-
stimulates VLCAD gene expression to 44% in normal and to 150% in VLCAD-deficient fibroblasts, increases activity 2.2fold in normal fibroblasts, induces a dose-dependent increase in palmitate oxidation capacities in cells from patients with the myopathic form of VLCAD deficiency, complete normalization of cell fatty acid oxidation capacities after exposure to 500 mM for 48 h, but not in cells from severely affected patients
bezafibrate
increased VLCAD residual enzyme activity in the presence of 0.4 mM bezafibrate